BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Suzuki H, Sato K, Takagi H, Kanda D, Sohara N, Kakizaki S, Nakajima H, Otsuka T, Nagamine T, Mori M. Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2. World J Gastroenterol 2006; 12(6): 945-950 [PMID: 16521225 DOI: 10.3748/wjg.v12.i6.945]
URL: https://www.wjgnet.com/1007-9327/full/v12/i6/945.htm
Number Citing Articles
1
Seyed-Moayed Alavian, Bita Behnava, Seyed Vahid Tabatabaei. Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysisEuropean Journal of Clinical Pharmacology 2010; 66(11): 1071 doi: 10.1007/s00228-010-0881-7
2
Ashwani K. Singal, Sarat C. Jampana, Steven A. Weinman. Antioxidants as therapeutic agents for liver diseaseLiver International 2011; 31(10): 1432 doi: 10.1111/j.1478-3231.2011.02604.x
3
Ronald L. Koretz. Advanced Nutrition and Dietetics in Nutrition Support2018; : 313 doi: 10.1002/9781118993880.ch5.11
4
Jin Hwi Kim, Seog Nyeon Bae, Chung Won Lee, Min Jong Song, Sung Jong Lee, Joo Hee Yoon, Keun Ho Lee, Soo Young Hur, Tae Chul Park, Jong Sup Park. A pilot study to investigate the treatment of cervical human papillomavirus infection with zinc-citrate compound (CIZAR®)Gynecologic Oncology 2011; 122(2): 303 doi: 10.1016/j.ygyno.2011.04.026
5
Takeaki Nagamine, Ken Sato, Satoru Kakizaki, Takahiro Satoh, Masashi Koka, Tomihiro Kamiya. Analysis of Erythrocyte Elements in Chronic Hepatitis C Patients Receiving PegIFN Monotherapy, Dual Therapy, and Triple Therapy using in-air MicroPIXEThe KITAKANTO Medical Journal 2016; 66(2): 91 doi: 10.2974/kmj.66.91